

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.86880863 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.63742621 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.63742621 |
| 4 | * positive regulation of B cell differentiation (GO:0045579) | 4.45047741 |
| 5 | * B cell receptor signaling pathway (GO:0050853) | 4.43969753 |
| 6 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.43913879 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.39808690 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.37458431 |
| 9 | negative regulation of cell killing (GO:0031342) | 4.36515843 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.36515843 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.29305532 |
| 12 | negative regulation of phagocytosis (GO:0050765) | 4.24395025 |
| 13 | immunoglobulin mediated immune response (GO:0016064) | 4.15516829 |
| 14 | detection of other organism (GO:0098543) | 4.08032018 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 4.06783193 |
| 16 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.02859830 |
| 17 | detection of bacterium (GO:0016045) | 3.95403747 |
| 18 | negative regulation of interleukin-12 production (GO:0032695) | 3.85089763 |
| 19 | * regulation of B cell differentiation (GO:0045577) | 3.85056730 |
| 20 | respiratory burst (GO:0045730) | 3.84374942 |
| 21 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.79741073 |
| 22 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.79741073 |
| 23 | modulation by symbiont of host immune response (GO:0052553) | 3.79741073 |
| 24 | positive regulation by symbiont of host defense response (GO:0052509) | 3.79741073 |
| 25 | modulation by symbiont of host defense response (GO:0052031) | 3.79741073 |
| 26 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.79741073 |
| 27 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.71230214 |
| 28 | ribosomal small subunit assembly (GO:0000028) | 3.69187872 |
| 29 | positive thymic T cell selection (GO:0045059) | 3.54274435 |
| 30 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.53139043 |
| 31 | mast cell activation (GO:0045576) | 3.46114600 |
| 32 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.43817403 |
| 33 | detection of external biotic stimulus (GO:0098581) | 3.39343391 |
| 34 | microglial cell activation (GO:0001774) | 3.36802563 |
| 35 | defense response to protozoan (GO:0042832) | 3.36168675 |
| 36 | B cell mediated immunity (GO:0019724) | 3.34140123 |
| 37 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.32080499 |
| 38 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.31786971 |
| 39 | response to host (GO:0075136) | 3.31786971 |
| 40 | response to host defenses (GO:0052200) | 3.31786971 |
| 41 | positive regulation of interferon-alpha production (GO:0032727) | 3.29829232 |
| 42 | cellular extravasation (GO:0045123) | 3.28345436 |
| 43 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.28313428 |
| 44 | response to peptidoglycan (GO:0032494) | 3.25296576 |
| 45 | T cell migration (GO:0072678) | 3.24426722 |
| 46 | definitive hemopoiesis (GO:0060216) | 3.24266131 |
| 47 | response to protozoan (GO:0001562) | 3.21775690 |
| 48 | regulation of leukocyte degranulation (GO:0043300) | 3.20826699 |
| 49 | cellular response to zinc ion (GO:0071294) | 3.20119199 |
| 50 | negative regulation of T cell mediated immunity (GO:0002710) | 3.16022400 |
| 51 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.15582883 |
| 52 | negative thymic T cell selection (GO:0045060) | 3.14711448 |
| 53 | myeloid dendritic cell activation (GO:0001773) | 3.14654252 |
| 54 | neutrophil activation (GO:0042119) | 3.13280884 |
| 55 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.11348624 |
| 56 | detection of molecule of bacterial origin (GO:0032490) | 3.10972017 |
| 57 | regulation of interferon-alpha production (GO:0032647) | 3.10362691 |
| 58 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.08568065 |
| 59 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.08475944 |
| 60 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.07854396 |
| 61 | myeloid cell activation involved in immune response (GO:0002275) | 3.05556848 |
| 62 | macrophage activation (GO:0042116) | 3.03045482 |
| 63 | macrophage activation involved in immune response (GO:0002281) | 3.01882560 |
| 64 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.01573425 |
| 65 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.99897143 |
| 66 | detection of biotic stimulus (GO:0009595) | 2.99505858 |
| 67 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.99482154 |
| 68 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.98832160 |
| 69 | megakaryocyte development (GO:0035855) | 2.98464737 |
| 70 | positive regulation of antigen processing and presentation (GO:0002579) | 2.97424427 |
| 71 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.96670619 |
| 72 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.96662368 |
| 73 | mast cell activation involved in immune response (GO:0002279) | 2.96270510 |
| 74 | mast cell degranulation (GO:0043303) | 2.96270510 |
| 75 | T cell homeostasis (GO:0043029) | 2.95956585 |
| 76 | DNA unwinding involved in DNA replication (GO:0006268) | 2.95717643 |
| 77 | regulation of mast cell activation (GO:0033003) | 2.95357069 |
| 78 | B cell homeostasis (GO:0001782) | 2.95162695 |
| 79 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.95161594 |
| 80 | T-helper 1 type immune response (GO:0042088) | 2.94792453 |
| 81 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.93364751 |
| 82 | regulation of mast cell degranulation (GO:0043304) | 2.91986141 |
| 83 | germinal center formation (GO:0002467) | 2.91580947 |
| 84 | actin nucleation (GO:0045010) | 2.91485878 |
| 85 | negative T cell selection (GO:0043383) | 2.91453711 |
| 86 | negative regulation of granulocyte differentiation (GO:0030853) | 2.89223550 |
| 87 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.89064515 |
| 88 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.88340898 |
| 89 | lymphocyte homeostasis (GO:0002260) | 2.87179757 |
| 90 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.86231590 |
| 91 | granulocyte activation (GO:0036230) | 2.85564285 |
| 92 | neutrophil mediated immunity (GO:0002446) | 2.83464973 |
| 93 | telomere maintenance via recombination (GO:0000722) | 2.81544047 |
| 94 | positive regulation of type 2 immune response (GO:0002830) | 2.81068596 |
| 95 | pinocytosis (GO:0006907) | 2.81026348 |
| 96 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.80746732 |
| 97 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.80746732 |
| 98 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.80554269 |
| 99 | positive regulation of mast cell degranulation (GO:0043306) | 2.80554269 |
| 100 | response to interferon-beta (GO:0035456) | 2.80115439 |
| 101 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.79538617 |
| 102 | mature B cell differentiation (GO:0002335) | 2.79122863 |
| 103 | regulation of gamma-delta T cell activation (GO:0046643) | 2.78588364 |
| 104 | DNA strand elongation (GO:0022616) | 2.77972055 |
| 105 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.77480172 |
| 106 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.76434100 |
| 107 | mitotic recombination (GO:0006312) | 2.75925632 |
| 108 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.75260452 |
| 109 | T cell selection (GO:0045058) | 2.75059643 |
| 110 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.73849462 |
| 111 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.73708630 |
| 112 | negative regulation of B cell proliferation (GO:0030889) | 2.72524331 |
| 113 | DNA topological change (GO:0006265) | 2.71967697 |
| 114 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.71735754 |
| 115 | positive regulation of mast cell activation (GO:0033005) | 2.70469888 |
| 116 | leukocyte aggregation (GO:0070486) | 2.69515966 |
| 117 | mature B cell differentiation involved in immune response (GO:0002313) | 2.69368452 |
| 118 | viral transcription (GO:0019083) | 2.68658202 |
| 119 | regulation of erythrocyte differentiation (GO:0045646) | 2.68267486 |
| 120 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.67608976 |
| 121 | positive regulation of macrophage differentiation (GO:0045651) | 2.67209046 |
| 122 | leukocyte degranulation (GO:0043299) | 2.66733351 |
| 123 | cellular response to interferon-beta (GO:0035458) | 2.62930489 |
| 124 | leukocyte homeostasis (GO:0001776) | 2.60248579 |
| 125 | positive regulation of granulocyte differentiation (GO:0030854) | 2.58101892 |
| 126 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.57464235 |
| 127 | response to host immune response (GO:0052572) | 2.55523849 |
| 128 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.55523849 |
| 129 | leukocyte mediated cytotoxicity (GO:0001909) | 2.54092507 |
| 130 | myeloid dendritic cell differentiation (GO:0043011) | 2.53961384 |
| 131 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.53663239 |
| 132 | myeloid leukocyte activation (GO:0002274) | 2.53534093 |
| 133 | translational termination (GO:0006415) | 2.52012422 |
| 134 | response to type I interferon (GO:0034340) | 2.50161202 |
| 135 | cellular response to type I interferon (GO:0071357) | 2.49555002 |
| 136 | type I interferon signaling pathway (GO:0060337) | 2.49555002 |
| 137 | regulation of antigen processing and presentation (GO:0002577) | 2.48437329 |
| 138 | positive regulation of interferon-beta production (GO:0032728) | 2.47151128 |
| 139 | response to fungus (GO:0009620) | 2.45326465 |
| 140 | regulation of granulocyte differentiation (GO:0030852) | 2.44614402 |
| 141 | response to muramyl dipeptide (GO:0032495) | 2.44388691 |
| 142 | natural killer cell differentiation (GO:0001779) | 2.43186385 |
| 143 | B cell proliferation (GO:0042100) | 2.39719173 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.52394763 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.30318536 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.97220890 |
| 4 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.46835405 |
| 5 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.44228620 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.13336918 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.13207488 |
| 8 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.13150002 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.06028971 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.79768897 |
| 11 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.74923963 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.73695359 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.70264544 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 2.66873259 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.59180785 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.51467660 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.46039514 |
| 18 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.42254971 |
| 19 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.37092803 |
| 20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.36500372 |
| 21 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.36236893 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.35507971 |
| 23 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.25315583 |
| 24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.25007208 |
| 25 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.24000907 |
| 26 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.18210209 |
| 27 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08848658 |
| 28 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.03585190 |
| 29 | MYB_26560356_Chip-Seq_TH2_Human | 1.98767471 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.97912443 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.96859799 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.96103862 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.95218942 |
| 34 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.95193197 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.92358469 |
| 36 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88749073 |
| 37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.84863726 |
| 38 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.84089509 |
| 39 | MAF_26560356_Chip-Seq_TH1_Human | 1.82617216 |
| 40 | GATA1_22025678_ChIP-Seq_K562_Human | 1.80605590 |
| 41 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.79549348 |
| 42 | MYB_26560356_Chip-Seq_TH1_Human | 1.78546904 |
| 43 | GATA1_19941826_ChIP-Seq_K562_Human | 1.76675974 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72337694 |
| 45 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.65986571 |
| 46 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.63947902 |
| 47 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.63491023 |
| 48 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.61105527 |
| 49 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.60590772 |
| 50 | UTX_26944678_Chip-Seq_JUKART_Human | 1.59930341 |
| 51 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.59329692 |
| 52 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.56349540 |
| 53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.53152852 |
| 54 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.50635141 |
| 55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50511069 |
| 56 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.49239630 |
| 57 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.48423755 |
| 58 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.47222117 |
| 59 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.45632817 |
| 60 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.45283790 |
| 61 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.40131103 |
| 62 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.40001340 |
| 63 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.37343033 |
| 64 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.35943247 |
| 65 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.35121194 |
| 66 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.34010483 |
| 67 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.33901695 |
| 68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.30016372 |
| 69 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.29125006 |
| 70 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28800421 |
| 71 | GATA2_19941826_ChIP-Seq_K562_Human | 1.27173529 |
| 72 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.26730534 |
| 73 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.23061163 |
| 74 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.20411746 |
| 75 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.19633641 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19369609 |
| 77 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.18400216 |
| 78 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.17894837 |
| 79 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17784717 |
| 80 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.16678366 |
| 81 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16090771 |
| 82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14743897 |
| 83 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.12054423 |
| 84 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.11807517 |
| 85 | MAF_26560356_Chip-Seq_TH2_Human | 1.09683720 |
| 86 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09473664 |
| 87 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08977195 |
| 88 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.08249586 |
| 89 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.08136129 |
| 90 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.07974271 |
| 91 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.07212369 |
| 92 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05117664 |
| 93 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.05075014 |
| 94 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.04273047 |
| 95 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.04028550 |
| 96 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03619366 |
| 97 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02684654 |
| 98 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02619693 |
| 99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02390574 |
| 100 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02185673 |
| 101 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.01265197 |
| 102 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.01102035 |
| 103 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00715412 |
| 104 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00189194 |
| 105 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.99909555 |
| 106 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.99773437 |
| 107 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99633892 |
| 108 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98110399 |
| 109 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.94756401 |
| 110 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94045027 |
| 111 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.94002914 |
| 112 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93135880 |
| 113 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91669286 |
| 114 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91004381 |
| 115 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90381124 |
| 116 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90056296 |
| 117 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89946439 |
| 118 | GATA3_26560356_Chip-Seq_TH2_Human | 0.89928987 |
| 119 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.89642844 |
| 120 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.89458066 |
| 121 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89225639 |
| 122 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.88215974 |
| 123 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.88152565 |
| 124 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.87920980 |
| 125 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87465204 |
| 126 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.87325213 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.66881328 |
| 2 | MP0002396_abnormal_hematopoietic_system | 3.30831218 |
| 3 | * MP0001800_abnormal_humoral_immune | 3.11213866 |
| 4 | MP0003436_decreased_susceptibility_to | 2.92259002 |
| 5 | * MP0002452_abnormal_antigen_presenting | 2.88369430 |
| 6 | MP0000685_abnormal_immune_system | 2.78298188 |
| 7 | * MP0005000_abnormal_immune_tolerance | 2.77894088 |
| 8 | * MP0005387_immune_system_phenotype | 2.71055515 |
| 9 | * MP0001790_abnormal_immune_system | 2.71055515 |
| 10 | * MP0002419_abnormal_innate_immunity | 2.70625898 |
| 11 | MP0009785_altered_susceptibility_to | 2.68744898 |
| 12 | MP0005671_abnormal_response_to | 2.64819161 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.61931752 |
| 14 | MP0005025_abnormal_response_to | 2.60249035 |
| 15 | * MP0002723_abnormal_immune_serum | 2.59024795 |
| 16 | * MP0002420_abnormal_adaptive_immunity | 2.57771253 |
| 17 | * MP0001819_abnormal_immune_cell | 2.54944673 |
| 18 | * MP0005464_abnormal_platelet_physiology | 2.52227056 |
| 19 | MP0003303_peritoneal_inflammation | 2.51744556 |
| 20 | * MP0002398_abnormal_bone_marrow | 2.45752876 |
| 21 | MP0004808_abnormal_hematopoietic_stem | 2.23269902 |
| 22 | MP0000465_gastrointestinal_hemorrhage | 2.21020685 |
| 23 | * MP0000716_abnormal_immune_system | 2.19790234 |
| 24 | * MP0000689_abnormal_spleen_morphology | 2.18959544 |
| 25 | MP0001545_abnormal_hematopoietic_system | 2.09058012 |
| 26 | MP0005397_hematopoietic_system_phenotyp | 2.09058012 |
| 27 | * MP0002722_abnormal_immune_system | 1.98954181 |
| 28 | MP0001853_heart_inflammation | 1.98785270 |
| 29 | MP0005058_abnormal_lysosome_morphology | 1.96139669 |
| 30 | * MP0002429_abnormal_blood_cell | 1.95922409 |
| 31 | MP0002405_respiratory_system_inflammati | 1.92626841 |
| 32 | MP0002166_altered_tumor_susceptibility | 1.92302582 |
| 33 | MP0008057_abnormal_DNA_replication | 1.92256331 |
| 34 | MP0010094_abnormal_chromosome_stability | 1.91098909 |
| 35 | MP0005174_abnormal_tail_pigmentation | 1.83050283 |
| 36 | MP0003693_abnormal_embryo_hatching | 1.82616436 |
| 37 | MP0003724_increased_susceptibility_to | 1.72203512 |
| 38 | MP0003763_abnormal_thymus_physiology | 1.69656099 |
| 39 | * MP0001845_abnormal_inflammatory_respons | 1.68384255 |
| 40 | MP0005451_abnormal_body_composition | 1.67182356 |
| 41 | MP0000490_abnormal_crypts_of | 1.65315435 |
| 42 | * MP0010155_abnormal_intestine_physiology | 1.61388266 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.61359310 |
| 44 | MP0002006_tumorigenesis | 1.61328436 |
| 45 | MP0009278_abnormal_bone_marrow | 1.60160008 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.57852270 |
| 47 | MP0006082_CNS_inflammation | 1.55958491 |
| 48 | MP0003191_abnormal_cellular_cholesterol | 1.51077886 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.50234360 |
| 50 | MP0003077_abnormal_cell_cycle | 1.44073184 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.43247019 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 1.40676475 |
| 53 | MP0008469_abnormal_protein_level | 1.40459372 |
| 54 | MP0000703_abnormal_thymus_morphology | 1.39003423 |
| 55 | MP0008260_abnormal_autophagy | 1.38878703 |
| 56 | MP0001873_stomach_inflammation | 1.38383297 |
| 57 | MP0003111_abnormal_nucleus_morphology | 1.36648255 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.34040045 |
| 59 | MP0010307_abnormal_tumor_latency | 1.31720402 |
| 60 | MP0004947_skin_inflammation | 1.29720522 |
| 61 | MP0008007_abnormal_cellular_replicative | 1.29475325 |
| 62 | MP0006054_spinal_hemorrhage | 1.25394094 |
| 63 | MP0003806_abnormal_nucleotide_metabolis | 1.22218125 |
| 64 | MP0009840_abnormal_foam_cell | 1.21253946 |
| 65 | MP0005310_abnormal_salivary_gland | 1.19943783 |
| 66 | MP0008058_abnormal_DNA_repair | 1.16419641 |
| 67 | MP0002019_abnormal_tumor_incidence | 1.15632746 |
| 68 | MP0003866_abnormal_defecation | 1.15294676 |
| 69 | MP0008004_abnormal_stomach_pH | 1.11411943 |
| 70 | MP0005075_abnormal_melanosome_morpholog | 1.10697735 |
| 71 | MP0009764_decreased_sensitivity_to | 1.10528641 |
| 72 | MP0000343_altered_response_to | 1.09748813 |
| 73 | MP0004510_myositis | 1.09108245 |
| 74 | MP0002095_abnormal_skin_pigmentation | 1.07887094 |
| 75 | MP0002009_preneoplasia | 1.07084969 |
| 76 | MP0000858_altered_metastatic_potential | 1.04361158 |
| 77 | MP0002138_abnormal_hepatobiliary_system | 1.04118565 |
| 78 | MP0004147_increased_porphyrin_level | 0.97149785 |
| 79 | MP0004957_abnormal_blastocyst_morpholog | 0.95786247 |
| 80 | MP0002132_abnormal_respiratory_system | 0.93864639 |
| 81 | MP0001986_abnormal_taste_sensitivity | 0.93836173 |
| 82 | MP0004883_abnormal_blood_vessel | 0.91752617 |
| 83 | MP0000015_abnormal_ear_pigmentation | 0.91017903 |
| 84 | MP0000604_amyloidosis | 0.90600179 |
| 85 | MP0003448_altered_tumor_morphology | 0.88524216 |
| 86 | MP0000569_abnormal_digit_pigmentation | 0.86860143 |
| 87 | MP0000313_abnormal_cell_death | 0.86579713 |
| 88 | MP0009763_increased_sensitivity_to | 0.80897595 |
| 89 | MP0002933_joint_inflammation | 0.80486214 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.79424938 |
| 91 | MP0003075_altered_response_to | 0.75417150 |
| 92 | MP0003828_pulmonary_edema | 0.69919895 |
| 93 | MP0010352_gastrointestinal_tract_polyps | 0.69841317 |
| 94 | MP0003690_abnormal_glial_cell | 0.69540325 |
| 95 | MP0002928_abnormal_bile_duct | 0.67689406 |
| 96 | MP0001663_abnormal_digestive_system | 0.65793751 |
| 97 | MP0005164_abnormal_response_to | 0.63917400 |
| 98 | MP0000371_diluted_coat_color | 0.63634511 |
| 99 | MP0008874_decreased_physiological_sensi | 0.63630300 |
| 100 | MP0000249_abnormal_blood_vessel | 0.63385079 |
| 101 | MP0004381_abnormal_hair_follicle | 0.62401019 |
| 102 | MP0005166_decreased_susceptibility_to | 0.62308304 |
| 103 | MP0003566_abnormal_cell_adhesion | 0.62029265 |
| 104 | MP0001915_intracranial_hemorrhage | 0.60824070 |
| 105 | MP0000598_abnormal_liver_morphology | 0.60367409 |
| 106 | MP0000350_abnormal_cell_proliferation | 0.60239199 |
| 107 | MP0003943_abnormal_hepatobiliary_system | 0.59533738 |
| 108 | MP0000609_abnormal_liver_physiology | 0.59079182 |
| 109 | MP0006036_abnormal_mitochondrial_physio | 0.58627117 |
| 110 | MP0001851_eye_inflammation | 0.57867136 |
| 111 | MP0008873_increased_physiological_sensi | 0.57743213 |
| 112 | MP0004782_abnormal_surfactant_physiolog | 0.55693256 |
| 113 | MP0003795_abnormal_bone_structure | 0.55589941 |
| 114 | MP0005621_abnormal_cell_physiology | 0.54880212 |
| 115 | MP0005390_skeleton_phenotype | 0.54808022 |
| 116 | MP0002998_abnormal_bone_remodeling | 0.54271973 |
| 117 | MP0002877_abnormal_melanocyte_morpholog | 0.54216258 |
| 118 | MP0002139_abnormal_hepatobiliary_system | 0.52616655 |
| 119 | MP0003221_abnormal_cardiomyocyte_apopto | 0.52230262 |
| 120 | MP0005083_abnormal_biliary_tract | 0.49399787 |
| 121 | MP0009115_abnormal_fat_cell | 0.48586495 |
| 122 | MP0005535_abnormal_body_temperature | 0.47328909 |
| 123 | MP0002693_abnormal_pancreas_physiology | 0.45262584 |
| 124 | MP0006035_abnormal_mitochondrial_morpho | 0.45218697 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Recurrent abscess formation (HP:0002722) | 5.32965448 |
| 2 | * Recurrent bacterial skin infections (HP:0005406) | 4.70385092 |
| 3 | * Cellulitis (HP:0100658) | 4.66649870 |
| 4 | IgM deficiency (HP:0002850) | 4.64302161 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.61784642 |
| 6 | * Agammaglobulinemia (HP:0004432) | 4.43403428 |
| 7 | Petechiae (HP:0000967) | 4.42849293 |
| 8 | * Recurrent viral infections (HP:0004429) | 4.09192948 |
| 9 | Recurrent fungal infections (HP:0002841) | 3.85703639 |
| 10 | Thrombocytosis (HP:0001894) | 3.84727959 |
| 11 | Prolonged bleeding time (HP:0003010) | 3.83205775 |
| 12 | * Meningitis (HP:0001287) | 3.73984177 |
| 13 | Stomatitis (HP:0010280) | 3.72021129 |
| 14 | Recurrent bronchitis (HP:0002837) | 3.67114108 |
| 15 | Colitis (HP:0002583) | 3.56781606 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.55254783 |
| 17 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.51810807 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 3.47492385 |
| 19 | Abnormality of macrophages (HP:0004311) | 3.37973701 |
| 20 | Inflammation of the large intestine (HP:0002037) | 3.35361429 |
| 21 | Myositis (HP:0100614) | 3.33257882 |
| 22 | Obstructive lung disease (HP:0006536) | 3.31064226 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 3.31064226 |
| 24 | * Recurrent skin infections (HP:0001581) | 3.27189097 |
| 25 | Gastrointestinal inflammation (HP:0004386) | 3.26402066 |
| 26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.26121400 |
| 27 | Gastrointestinal stroma tumor (HP:0100723) | 3.21975889 |
| 28 | Recurrent pneumonia (HP:0006532) | 3.05889294 |
| 29 | B lymphocytopenia (HP:0010976) | 3.03320031 |
| 30 | Abnormality of B cell number (HP:0010975) | 3.03320031 |
| 31 | * Chronic otitis media (HP:0000389) | 3.00637157 |
| 32 | * Osteomyelitis (HP:0002754) | 2.99111854 |
| 33 | Vacuolated lymphocytes (HP:0001922) | 2.98863881 |
| 34 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.98626544 |
| 35 | Recurrent cutaneous fungal infections (HP:0011370) | 2.98626544 |
| 36 | Abnormal platelet volume (HP:0011876) | 2.96461131 |
| 37 | Vasculitis (HP:0002633) | 2.95170582 |
| 38 | Gastrointestinal infarctions (HP:0005244) | 2.93184182 |
| 39 | Abnormality of T cell physiology (HP:0011840) | 2.90518387 |
| 40 | Verrucae (HP:0200043) | 2.90309475 |
| 41 | Papilloma (HP:0012740) | 2.90309475 |
| 42 | Recurrent lower respiratory tract infections (HP:0002783) | 2.89538590 |
| 43 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.88418418 |
| 44 | Increased cerebral lipofuscin (HP:0011813) | 2.88089592 |
| 45 | Lymphopenia (HP:0001888) | 2.86834176 |
| 46 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.85028928 |
| 47 | Chest pain (HP:0100749) | 2.84750034 |
| 48 | Epistaxis (HP:0000421) | 2.82851485 |
| 49 | * Panhypogammaglobulinemia (HP:0003139) | 2.81605023 |
| 50 | Thyroiditis (HP:0100646) | 2.73209881 |
| 51 | Reticulocytopenia (HP:0001896) | 2.68857422 |
| 52 | Abnormal platelet function (HP:0011869) | 2.65534790 |
| 53 | Impaired platelet aggregation (HP:0003540) | 2.65534790 |
| 54 | Spontaneous hematomas (HP:0007420) | 2.63501424 |
| 55 | T lymphocytopenia (HP:0005403) | 2.62367581 |
| 56 | Abnormality of glycolipid metabolism (HP:0010969) | 2.61376250 |
| 57 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.61376250 |
| 58 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.61376250 |
| 59 | Recurrent sinusitis (HP:0011108) | 2.60719348 |
| 60 | Keratoconjunctivitis sicca (HP:0001097) | 2.59812044 |
| 61 | Abnormal number of erythroid precursors (HP:0012131) | 2.58833153 |
| 62 | Purpura (HP:0000979) | 2.58243641 |
| 63 | Chronic sinusitis (HP:0011109) | 2.58226707 |
| 64 | Autoimmune thrombocytopenia (HP:0001973) | 2.56722457 |
| 65 | Autoimmune hemolytic anemia (HP:0001890) | 2.56113944 |
| 66 | Systemic lupus erythematosus (HP:0002725) | 2.56063968 |
| 67 | Gingival bleeding (HP:0000225) | 2.53007451 |
| 68 | Abnormality of T cell number (HP:0011839) | 2.52771103 |
| 69 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.52745996 |
| 70 | Nasal polyposis (HP:0100582) | 2.51189389 |
| 71 | Increased mean platelet volume (HP:0011877) | 2.51107061 |
| 72 | Increased serum ferritin (HP:0003281) | 2.49909527 |
| 73 | Hemoptysis (HP:0002105) | 2.45435832 |
| 74 | Pustule (HP:0200039) | 2.44085876 |
| 75 | Lymphoma (HP:0002665) | 2.42594315 |
| 76 | Abnormality of T cells (HP:0002843) | 2.42346924 |
| 77 | Interstitial pulmonary disease (HP:0006530) | 2.41874080 |
| 78 | IgG deficiency (HP:0004315) | 2.40202358 |
| 79 | Abnormality of iron homeostasis (HP:0011031) | 2.37366146 |
| 80 | Increased IgM level (HP:0003496) | 2.36352907 |
| 81 | Keratoconjunctivitis (HP:0001096) | 2.36198611 |
| 82 | Aplastic anemia (HP:0001915) | 2.36012656 |
| 83 | Granulocytopenia (HP:0001913) | 2.35999797 |
| 84 | Amaurosis fugax (HP:0100576) | 2.35509927 |
| 85 | Gingivitis (HP:0000230) | 2.35212988 |
| 86 | Hepatosplenomegaly (HP:0001433) | 2.34042671 |
| 87 | Agnosia (HP:0010524) | 2.32123435 |
| 88 | Periodontitis (HP:0000704) | 2.31522104 |
| 89 | IgA deficiency (HP:0002720) | 2.30526589 |
| 90 | * Sepsis (HP:0100806) | 2.28383277 |
| 91 | Leukocytosis (HP:0001974) | 2.28303609 |
| 92 | Eosinophilia (HP:0001880) | 2.27415354 |
| 93 | Abnormality of the nasal mucosa (HP:0000433) | 2.27023362 |
| 94 | Orchitis (HP:0100796) | 2.25664450 |
| 95 | Hypertensive crisis (HP:0100735) | 2.25024533 |
| 96 | Neutropenia (HP:0001875) | 2.24059933 |
| 97 | Acute myeloid leukemia (HP:0004808) | 2.18292873 |
| 98 | Myelodysplasia (HP:0002863) | 2.17386027 |
| 99 | Hypergammaglobulinemia (HP:0010702) | 2.15789109 |
| 100 | Pulmonary embolism (HP:0002204) | 2.14425722 |
| 101 | * Encephalitis (HP:0002383) | 2.13628362 |
| 102 | Optic neuritis (HP:0100653) | 2.12704771 |
| 103 | Retrobulbar optic neuritis (HP:0100654) | 2.12704771 |
| 104 | Urticaria (HP:0001025) | 2.12184447 |
| 105 | Loss of speech (HP:0002371) | 2.11676996 |
| 106 | * Skin rash (HP:0000988) | 2.10126865 |
| 107 | Reduced antithrombin III activity (HP:0001976) | 2.09533885 |
| 108 | Polycythemia (HP:0001901) | 2.08634918 |
| 109 | Thoracic kyphosis (HP:0002942) | 2.07981311 |
| 110 | Leukopenia (HP:0001882) | 2.06387699 |
| 111 | Abnormality of the fingertips (HP:0001211) | 2.05597514 |
| 112 | Emphysema (HP:0002097) | 2.04682408 |
| 113 | * Skin ulcer (HP:0200042) | 2.03460986 |
| 114 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.02444154 |
| 115 | Dysostosis multiplex (HP:0000943) | 2.01569942 |
| 116 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.01520759 |
| 117 | Episodic fever (HP:0001954) | 2.00860049 |
| 118 | Abnormality of the thoracic spine (HP:0100711) | 2.00771659 |
| 119 | Abnormality of the pleura (HP:0002103) | 2.00732444 |
| 120 | Pulmonary infiltrates (HP:0002113) | 2.00341976 |
| 121 | * Abnormality of the prostate (HP:0008775) | 1.99807055 |
| 122 | Disinhibition (HP:0000734) | 1.98592797 |
| 123 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.97921119 |
| 124 | Fatigue (HP:0012378) | 1.97602600 |
| 125 | Restrictive lung disease (HP:0002091) | 1.96398548 |
| 126 | Bronchitis (HP:0012387) | 1.95945759 |
| 127 | Arterial thrombosis (HP:0004420) | 1.93392090 |
| 128 | Increased IgE level (HP:0003212) | 1.92475621 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.83763284 |
| 2 | BLK | 3.29453573 |
| 3 | KIT | 3.12865959 |
| 4 | IRAK4 | 3.00263766 |
| 5 | PRPF4B | 2.73879435 |
| 6 | CSF1R | 2.56531246 |
| 7 | MAP3K14 | 2.56208859 |
| 8 | EEF2K | 2.49781724 |
| 9 | * BTK | 2.37123461 |
| 10 | RIPK4 | 2.11708325 |
| 11 | TYK2 | 2.09693790 |
| 12 | * SYK | 2.06890894 |
| 13 | BMPR2 | 2.02622009 |
| 14 | TBK1 | 1.89065668 |
| 15 | ERN1 | 1.82165622 |
| 16 | TAOK3 | 1.76234792 |
| 17 | STK10 | 1.70659006 |
| 18 | CLK1 | 1.67367936 |
| 19 | ZAP70 | 1.65248387 |
| 20 | FES | 1.63372017 |
| 21 | GRK6 | 1.62827183 |
| 22 | PIM2 | 1.61683034 |
| 23 | MAP2K3 | 1.57195310 |
| 24 | MAP3K10 | 1.53520676 |
| 25 | JAK3 | 1.53213677 |
| 26 | * TEC | 1.52148703 |
| 27 | IKBKB | 1.50302811 |
| 28 | TGFBR2 | 1.50068018 |
| 29 | IRAK3 | 1.49344796 |
| 30 | FLT3 | 1.47275975 |
| 31 | * LYN | 1.45991642 |
| 32 | FGR | 1.45067404 |
| 33 | CDC7 | 1.42714211 |
| 34 | LRRK2 | 1.37749644 |
| 35 | CCNB1 | 1.34252799 |
| 36 | HCK | 1.33123955 |
| 37 | PIM1 | 1.32848255 |
| 38 | WEE1 | 1.25902150 |
| 39 | MATK | 1.24003481 |
| 40 | IKBKE | 1.23207894 |
| 41 | NEK2 | 1.19001590 |
| 42 | EIF2AK1 | 1.16343064 |
| 43 | TXK | 1.11620863 |
| 44 | STK4 | 1.07924378 |
| 45 | RPS6KA4 | 1.05435603 |
| 46 | EIF2AK3 | 1.01749975 |
| 47 | NME2 | 1.01388964 |
| 48 | RPS6KB2 | 1.01214653 |
| 49 | MAP3K11 | 1.00857834 |
| 50 | JAK1 | 0.98819788 |
| 51 | * LCK | 0.98335480 |
| 52 | TAOK2 | 0.97884798 |
| 53 | STK16 | 0.96863473 |
| 54 | SCYL2 | 0.94575853 |
| 55 | PKN2 | 0.92345583 |
| 56 | MAP3K1 | 0.91104085 |
| 57 | BRSK2 | 0.90375037 |
| 58 | SMG1 | 0.87672795 |
| 59 | CDK4 | 0.86769182 |
| 60 | CSK | 0.86366376 |
| 61 | ATR | 0.82932142 |
| 62 | TESK2 | 0.82677577 |
| 63 | MAP3K13 | 0.80898604 |
| 64 | BUB1 | 0.79801299 |
| 65 | IRAK1 | 0.78258086 |
| 66 | PDK1 | 0.76664149 |
| 67 | SIK2 | 0.75940863 |
| 68 | TGFBR1 | 0.75321946 |
| 69 | VRK1 | 0.75005875 |
| 70 | CHUK | 0.72515374 |
| 71 | CDK6 | 0.71431218 |
| 72 | MAPK4 | 0.71007135 |
| 73 | TRPM7 | 0.69859065 |
| 74 | MAPK12 | 0.69098673 |
| 75 | KSR2 | 0.67636770 |
| 76 | JAK2 | 0.65233667 |
| 77 | MAP3K3 | 0.64217009 |
| 78 | IRAK2 | 0.61465747 |
| 79 | PDPK1 | 0.60092412 |
| 80 | ACVR1B | 0.59654997 |
| 81 | CDK12 | 0.59341439 |
| 82 | NEK9 | 0.59190301 |
| 83 | MAP3K5 | 0.58304996 |
| 84 | MAP3K8 | 0.57502420 |
| 85 | TAOK1 | 0.56808383 |
| 86 | DYRK3 | 0.53866331 |
| 87 | RPS6KA6 | 0.52294653 |
| 88 | MKNK1 | 0.49837946 |
| 89 | MAPKAPK5 | 0.49271741 |
| 90 | * ITK | 0.49191474 |
| 91 | MAPK11 | 0.47965441 |
| 92 | TNK2 | 0.47846235 |
| 93 | CDC42BPA | 0.47591038 |
| 94 | AURKB | 0.47496651 |
| 95 | MAPK7 | 0.47430182 |
| 96 | PASK | 0.47341828 |
| 97 | SIK3 | 0.47333550 |
| 98 | TRIB3 | 0.47135231 |
| 99 | MAPKAPK2 | 0.46286862 |
| 100 | MAP3K6 | 0.46218825 |
| 101 | PRKCD | 0.45335172 |
| 102 | EPHB1 | 0.45026010 |
| 103 | PAK4 | 0.44777243 |
| 104 | YES1 | 0.44633220 |
| 105 | PIK3CG | 0.44498484 |
| 106 | HIPK2 | 0.44151968 |
| 107 | RAF1 | 0.43462290 |
| 108 | FYN | 0.43008784 |
| 109 | RPS6KC1 | 0.42696719 |
| 110 | RPS6KL1 | 0.42696719 |
| 111 | CDK7 | 0.42447153 |
| 112 | PRKCQ | 0.41720426 |
| 113 | EIF2AK2 | 0.41266874 |
| 114 | STK24 | 0.40895675 |
| 115 | MARK3 | 0.40873616 |
| 116 | ALK | 0.40839072 |
| 117 | TSSK6 | 0.40681343 |
| 118 | BMX | 0.39814004 |
| 119 | CAMK1D | 0.38150002 |
| 120 | GRK7 | 0.37347815 |
| 121 | BRSK1 | 0.36688949 |
| 122 | MARK2 | 0.36597169 |
| 123 | FGFR3 | 0.34434920 |
| 124 | CDK19 | 0.33490024 |
| 125 | MAPKAPK3 | 0.33374992 |
| 126 | TLK1 | 0.33345604 |
| 127 | MAP3K12 | 0.33085802 |
| 128 | EGFR | 0.32297230 |
| 129 | * ABL1 | 0.32244024 |
| 130 | MAPK3 | 0.30619083 |
| 131 | BCKDK | 0.25080875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.29976612 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.08297753 |
| 3 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.99159643 |
| 4 | * Primary immunodeficiency_Homo sapiens_hsa05340 | 2.88737506 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 2.65270517 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.61911022 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.50342424 |
| 8 | Mismatch repair_Homo sapiens_hsa03430 | 2.26272082 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.11032811 |
| 10 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.08023842 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.04539075 |
| 12 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.00057110 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.99457590 |
| 14 | Ribosome_Homo sapiens_hsa03010 | 1.98689827 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.90296020 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.89426207 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.86098033 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.85051620 |
| 19 | Homologous recombination_Homo sapiens_hsa03440 | 1.77740442 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.72625872 |
| 21 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.68594035 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.68453159 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.66394200 |
| 24 | Legionellosis_Homo sapiens_hsa05134 | 1.65898888 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.60484640 |
| 26 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.59246720 |
| 27 | Pertussis_Homo sapiens_hsa05133 | 1.55899536 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.54517235 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 1.53284291 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.44936430 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.41501309 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.35256826 |
| 33 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.32858919 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.32045954 |
| 35 | Spliceosome_Homo sapiens_hsa03040 | 1.28764511 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.27547801 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26098864 |
| 38 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.21804749 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.21381578 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 1.21148702 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.20445686 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.20261686 |
| 43 | Malaria_Homo sapiens_hsa05144 | 1.19434670 |
| 44 | Cell cycle_Homo sapiens_hsa04110 | 1.19354429 |
| 45 | Asthma_Homo sapiens_hsa05310 | 1.15000143 |
| 46 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.08317314 |
| 47 | * Platelet activation_Homo sapiens_hsa04611 | 1.07432706 |
| 48 | Allograft rejection_Homo sapiens_hsa05330 | 1.07413019 |
| 49 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.07011509 |
| 50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.06893113 |
| 51 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.06032814 |
| 52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.05163175 |
| 53 | Lysosome_Homo sapiens_hsa04142 | 1.03760589 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.03735384 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.01187027 |
| 56 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.95509420 |
| 57 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.93786502 |
| 58 | Salmonella infection_Homo sapiens_hsa05132 | 0.92704181 |
| 59 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.91136362 |
| 60 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.90378908 |
| 61 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.89594395 |
| 62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87835857 |
| 63 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86616148 |
| 64 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.86519968 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.85436619 |
| 66 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.81016174 |
| 67 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.80380911 |
| 68 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.80108623 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79817647 |
| 70 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.77010113 |
| 71 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76470105 |
| 72 | RNA degradation_Homo sapiens_hsa03018 | 0.75477702 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74755437 |
| 74 | RNA transport_Homo sapiens_hsa03013 | 0.73085912 |
| 75 | Proteasome_Homo sapiens_hsa03050 | 0.71737183 |
| 76 | RNA polymerase_Homo sapiens_hsa03020 | 0.66795074 |
| 77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.66673030 |
| 78 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.65911662 |
| 79 | Phagosome_Homo sapiens_hsa04145 | 0.64550710 |
| 80 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.63798390 |
| 81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63337987 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.62267068 |
| 83 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.61909805 |
| 84 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61734592 |
| 85 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60755477 |
| 86 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.60723897 |
| 87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59185960 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.57359178 |
| 89 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.57292924 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56688226 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55717430 |
| 92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55376481 |
| 93 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55341095 |
| 94 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55238872 |
| 95 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50700912 |
| 96 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47154832 |
| 97 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.46498753 |
| 98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.41820770 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40369827 |
| 100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38966926 |
| 101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.38727967 |
| 102 | ABC transporters_Homo sapiens_hsa02010 | 0.38507656 |
| 103 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.38396388 |
| 104 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.38246947 |
| 105 | Basal transcription factors_Homo sapiens_hsa03022 | 0.37348561 |
| 106 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36542649 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34905298 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32699736 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32471712 |
| 110 | Purine metabolism_Homo sapiens_hsa00230 | 0.31270048 |
| 111 | Colorectal cancer_Homo sapiens_hsa05210 | 0.31232061 |
| 112 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.30295847 |
| 113 | Endocytosis_Homo sapiens_hsa04144 | 0.29872534 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.29309850 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28898653 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28390504 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.25618384 |
| 118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.24118719 |
| 119 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.23564671 |
| 120 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.22973413 |
| 121 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.21418470 |
| 122 | Bladder cancer_Homo sapiens_hsa05219 | 0.20141041 |
| 123 | Amoebiasis_Homo sapiens_hsa05146 | 0.19387526 |
| 124 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.18021814 |
| 125 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.17666084 |
| 126 | Insulin resistance_Homo sapiens_hsa04931 | 0.16353522 |
| 127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.16072734 |
| 128 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.16003816 |
| 129 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.13453224 |
| 130 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.12767366 |

